RISIKO SERANGAN STROKE AKIBAT PENYAKIT HIPERTENSI YANG TIDAK TERKONTROL: LAPORAN KASUS

Julaeha Julaeha

Abstract


Stroke is a neurological function disorder caused by cerebral blood circulation disorders. Stroke is the leading cause of long-term disability. Non-hemorrhagic stroke or ischemic stroke is 88% of all stroke cases. In this case, the stroke patient was 61 years old with a history of hypertension, hyperuricemia and after calculating the patient's  Body Mass Index (BMI) of 34.78, it was included in the class I obesity range. The choice of hypertension drug plays a very important role in stabilizing the patient's stroke and if the blood clot in the brain is not repaired immediately then can lead to death. Drug Therapy Problems (DTPs) that occur in this case were the serious drug interactions between Amlodipine and Simvastatin  and the major interactions between candesartan and piroxicam were in the pharmacokinetic phase and include major interactions.


Keywords


Cardiovascular disease; stroke; hypertension; Drug Therapy Problems

References


Suntara D, Roza N, Rahmah A. Hubungan Hipertensi Dengan Kejadian Stroke Pada Lansia Di Wilayah Kerja Puskesmas Sekupang Keluarahan Tanjung Riau Kota Batam. Jurnal Inovasi Penelitian.2021; 1(10):2177-2184.

Handayani D, dan Dominica D. Gambaran Drug Related Problems (DRP’s) pada Penatalaksanaan Pasien Stroke Hemoragik dan Stroke Non Hemoragik di RSUD Dr. M Yunus Bengkulu. Jurnal Farmasi Dan Ilmu Kefarnasian Indonesia. 2018; 5(1):36-44.

Dipiro.JT. Parmacoterapy Handbook 7th Edition. New York:Mc Graw Hill;2009.

Idacahyati K, Nofianti T, Aswa GA, Nurfatwa M. Hubungan Tingkat Kejadian Efek Samping Antiinflamasi Non Steroid dengan Usia dan Jenis Kelamin. Jurnal Farmasi dan Ilmu Kefarmasian Indonesia. 2019; 6(2):56-61.

Dewi IP, dan Merry MS. Peranan Obat Golongan Statin. Berkala Ilmiah Kedokteran Duta Wacana. 2017; 2(3):iii-v.

American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009 Jan 27;119(3):e21-181.

PCNE. PCNE Classification for Drug related problems V9.00. Europe: Pharmaceutical Care Network Europe Association;2019.

Yunaidi, Y. Intervensi pada Stroke Non- Hemoragik. Jurnal Kardiologi Indonesia. 2010; 31(3):153-155.

Utami PR. Handayani RP. Puspitasari VDA. Potensi interaksi obat pada pasien geriatri yang menggunakan Antihipertensi di puskesmas karanggeneng lamongan. Jurnal Surya. 2020; 12(2):70-76.

Juwita DA, Almasdy D, Hardini T. Evaluasi Penggunaan Obat Antihipertensi pada Pasien Stroke Iskemik di Rumah Sakit Stroke Nasional Bukittinggi. Jurnal Farmasi Klinik Indonesia. 2018; 7(2):99-107.

Fahreza F, Hasni D, Vani AT, Jelmila SN. Gambaran kadar total kolesterol pada pasien prolasis yang mendapat terapi simvastatin di puskesmas air dingin 2018. Jurnal Ibnu Sina. 2020; 19(2):53-62.

Veryanti PR. Dan Safira I. Kajian Interaksi Obat Pada Pasien Strok Di Rumah Sakit Pusat Otak Nasional. Jurnal Ilmiah Medicamento. 2020; 6(1):45-52.

Hidayah K, Kundarto W, Farida Y. Identifikasi Potensi Interaksi Obat pada Peresepan Obat Pasien Hipertensi dengan Diabetes Mellitus. Jurnal Annual Pharmacy Conference. 2017;108-120.

Zahra AP. dan Carolia N. Obat Anti-Inflamasi Non-Steroid (OAINS): Gastroprotektif vs Kardiotoksik. Majority. 2017; 6(3):153-158.




DOI: https://doi.org/10.52447/scpij.v8i2.6997

Refbacks

  • There are currently no refbacks.